Skip to content

Clinical Effectiveness Study of Unstable Angina of Treating Coronary Heart Disease with Yang Deficiency and Blood Stasis Syndrome with Wenxin Decoction Combined with Western Medicine

Clinical Effectiveness Study of Effective Chinese Medicinal Formulae Intervention on Unstable Angina of Coronary Heart Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016515
Enrollment
Unknown
Registered
2018-06-05
Start date
2018-06-30
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unstable Angina of Coronary Heart Disease

Interventions

test group:Western Medicine+Wenxin Decoction
Control group:Western Medicine

Sponsors

China Academy of Chinese Medical Sciences Guang'anmen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 35-80 patient; 2. Coronary heart disease diagnosed by coronary angiography or coronary CTA, and one of the following: 1) The original nature of stable angina, ie, frequent episodes of angina, severe degree and prolonged duration; 2) Angina attack at rest; 3) Angina pectoris that can be induced by recent mild physical activity within the last month; 3. Dialectic of TCM is the person of Yang deficiency and blood stasis.

Exclusion criteria

Exclusion criteria: Stable angina; Acute myocardial infarction; Chest pain due to other congenital heart diseases, valvular disease, severe neurosis, etc.; Heart function class III or IV; chest distress chest pain caused by arrhythmia; acute phase of cerebral infarction; , kidney, hematopoietic system and other serious primary diseases; acute infection in the last 2 weeks; combined with other more serious and must be treated (such as blood diseases, tumors, etc.); uncontrolled high blood pressure (rest blood pressure within one week> 160/95mmHg); Diabetes mellitus did not meet the general control standards, or more serious diabetic complications; Mental, neurological or mental disorders can not complete a questionnaire; Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Platelet function;

Secondary

MeasureTime frame
Routine blood examination;Myocardial zymography;Blood lipid detection;DIC test;

Countries

China

Contacts

Public ContactLi Jun

Guang'anmen Hospital

gamyylj@163.com+86 15811093831

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026